| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Glaucoma |
|
| Public Comment on Draft Recommendation Statement and Evidence Review: Screening for Impaired Vision |
|
| Final Research Plan: Folic Acid to Prevent Neural Tube Defects |
|
| Public Comment on Draft Recommendation Statement and Draft Evidence Review: Screening for Eating Disorders |
|
| Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease |
|
| Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality |
|
| Final Recommendation Statement: Screening for Chlamydia and Gonorrhea |
|
| Final Research Plan: Screening for Hypertensive Disorders of Pregnancy |
|
| Final Recommendation Statement: Screening for Prediabetes and Type 2 Diabetes |
|
| Final Research Plan: Screening for Lipid Disorders in Youth |
|
| Public Comment on Draft Research Plan: Screening for Osteoporosis |
|
| Final Recommendation Statement: Screening for Gestational Diabetes |
|
| Public Comment on Draft Research Plan: Folic Acid to Prevent Neural Tube Defects |
|
| Public Comment on Draft Research Plan: Screening for Genital Herpes |
|
| Final Research Plan: Oral Health in Youth and Adults |
|
| Final Research Plan: Screening for Latent Tuberculosis Infection in Adults |
|
| Final Research Plan: Screening for Autism |
|
| Final Research Plan: Menopausal Hormone Therapy for the Prevention of Chronic Conditions |
|
| Final Recommendation Statement: Counseling for Healthy Weight and Weight Gain in Pregnancy |
|
| Public Comment on Draft Research Plan: Screening for Hypertensive Disorders of Pregnancy |
|
